Clinical trials: MEK Inhibitor-Associated Retinopathy
MEK Inhibitor-Associated Serous Retinopathy
Investigation of Potential Retinal Toxicity Associated With Hair Dye Products Containing pPD Type Aromatic Amines
Hair dye products could induce minimal forms of MEKAR retinopathies (Mitogen-activated Extracellular signal-regulated Kinase - inhibitors associated retinopathies).
- Trial name
- CAPITOX (NCT04222387)
- Testing
- OCT-B scan
- Where
- France
- Volunteers
- 62 people, healthy volunteers welcome
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild